Marcel Fontecha

Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes

Lisa Madlensky, Loki Natarajan, Simone Tchu et al. · Clinical Pharmacology & Therapeutics · 2011 · 329 citations · Full text

Medicine, Oncology, Pharmacology +16

Frizzled‐related protein variants are risk factors for hip osteoarthritis

Nancy E. Lane, Ke Lian, Michael C. Nevitt et al. · Arthritis & Rheumatism · 2006 · 131 citations

Medicine, Genetics, Orthopaedic Surgery +17

Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy

Alastair M. Thompson, Andrea Johnson, Philip Quinlan et al. · Breast Cancer Research and Treatment · 2010 · 85 citations

Medicine, Oncology, Pharmacology +13

Genetic Determinants of Cardiovascular Disease Risk in Familial Hypercholesterolemia

Angelique C.M. Jansen, Emily Cohen, Michael W.T. Tanck et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 63 citations

Medicine, Genetics, Molecular Genetics +17

Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemia

Emily Cohen, Angelique C.M. Jansen, S. Matthijs Boekholdt et al. · European Journal of Human Genetics · 2005 · 33 citations

Medicine, Genetics, Molecular Genetics +16